Polymer Capital Management (HK)’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,520	Closed	-$399K	–	233
2024 Q1	$399K	Buy	+10,520	New	+$399K	0.1%	117